Fibrotic hypersensitivity pneumonitis
MONDO:0975896A chronic, progressive lung disease characterized by inflammation and scarring (fibrosis) of the lung tissue, caused by an immune response to inhaled antigens.
77 clinical trials for this condition and its sub-types, 9 tagged with Fibrotic hypersensitivity pneumonitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New combo therapy aims to slow lung scarring in hypersensitivity pneumonitis
Disease control OngoingThis phase 4 trial tests whether adding mycophenolate mofetil (MMF) to standard prednisolone treatment works better than prednisolone alone for fibrotic hypersensitivity pneumonitis, a lung condition where scarring makes breathing hard. About 144 adults with at least 40% predicte…
Phase 4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Breathing in xenon: a new MRI scan to see lung damage?
Knowledge-focused OngoingThis study at Duke University tests whether a special MRI scan using inhaled xenon gas can detect changes in lung function over time in people with progressive pulmonary fibrosis. Sixty adults with various types of lung scarring will have MRI scans before starting anti-fibrotic m…
Phase 2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC